These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2598022)

  • 1. A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH
    Brain Res; 1989 Dec; 504(2):192-8. PubMed ID: 2598022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine.
    Vanderwolf CH; Leung LW; Baker GB; Stewart DJ
    Brain Res; 1989 Dec; 504(2):181-91. PubMed ID: 2598021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
    Pranzatelli MR; Huang YY; Dollison AM; Stanley M
    Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
    Pranzatelli MR; Dollison AM; Hlibczuk V
    Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of microinjections of 5,7-dihydroxytryptamine in the suprachiasmatic nuclei of the rat on serotonin reuptake and the circadian variation of corticosterone levels.
    Williams JH; Miall-Allen VM; Klinowski M; Azmitia EC
    Neuroendocrinology; 1983 Jun; 36(6):431-5. PubMed ID: 6877522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and behavioral alterations in developing rats treated with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Mueller RA
    J Pharmacol Exp Ther; 1978 Jun; 205(3):587-95. PubMed ID: 307057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
    Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
    Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: co-operative interactions of serotonin and dopamine in neostriatum.
    Waddington JL; Crow TJ
    Life Sci; 1979 Oct; 25(15):1307-14. PubMed ID: 316093
    [No Abstract]   [Full Text] [Related]  

  • 11. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
    Hole K; Johnson GE; Berge OG
    Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5,7-DHT-induced muricide: inhibition as a result of preoperative exposure of rats to mice.
    Marks PC; O'Brien M; Paxinos G
    Brain Res; 1977 Oct; 135(2):383-8. PubMed ID: 562701
    [No Abstract]   [Full Text] [Related]  

  • 13. Locomotor activity and ingestive behavior after damage to ascending serotonergic systems.
    Heym J; Gladfelter WE
    Physiol Behav; 1982 Sep; 29(3):459-67. PubMed ID: 7178251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat.
    Lorden JF; Oltmans GA; Dawson R; Callahan M
    Pharmacol Biochem Behav; 1979 Jan; 10(1):79-86. PubMed ID: 312504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
    Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
    Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model of central chemical 'serotoninectomy' in mice.
    Herman ZS; Bonczek A
    Pharmacology; 1978; 17(1):8-14. PubMed ID: 684075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tilt-cage activity after serotonin depletion by 5,7-dihydroxytryptamine.
    Mackenzie RG; Hoebel BG; Norelli HC; Trulson ME
    Neuropharmacology; 1978 Nov; 17(11):957-63. PubMed ID: 152872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.